Literature DB >> 8381299

Cutaneous leishmaniasis in British troops from Belize.

N C Hepburn1, M J Tidman, J A Hunter.   

Abstract

The medical records of 306 British soldiers in whom a clinical diagnosis of cutaneous leishmaniasis had been made following a tour of duty in Belize were analysed. Parasitological confirmation of the diagnosis was established in 187 cases; leishmania were cultured in 117 cases and Leishman-Donovan bodies were identified histologically in a further 70 cases. Leishmania braziliensis braziliensis was identified in 78 cases and Leishmania mexicana mexicana in a further 29 cases. Seventy-one per cent of patients had a single lesion which, in most cases, occurred on the exposed extremities. The mean diameter of the ulcers was 14.4 mm. Treatment with sodium stibogluconate was effective. Two regimens were used, consisting of either 600-800 mg daily given initially for 10 days, or 600 mg b.d. given initially for 14 days. Of those allocated to the lower dose regimen 48.5% were cured after the initial 10-day course, and ultimately the ulcers of 93% of patients healed following more prolonged treatment at this dose. Of those allocated to the higher dose regimen 63.9% were cured after the initial 14-day course and ultimately the ulcers of all patients healed after more prolonged treatment at this dose. A transient leucopenia and a rise in liver enzymes were noted during treatment, and these changes were dose-dependent. No cases of mucocutaneous leishmaniasis were encountered.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8381299     DOI: 10.1111/j.1365-2133.1993.tb00149.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  8 in total

1.  A controlled, randomized-blinded clinical trial to assess the efficacy of a nitric oxide releasing patch in the treatment of cutaneous leishmaniasis by Leishmania (V.) panamensis.

Authors:  Patricio López-Jaramillo; Melvin Y Rincón; Ronald G García; Sandra Y Silva; Erin Smith; Piyaporn Kampeerapappun; Carlos García; Daniel J Smith; Marcos López; Iván D Vélez
Journal:  Am J Trop Med Hyg       Date:  2010-07       Impact factor: 2.345

2.  [Cutaneous leishmaniasis--an import from Belize].

Authors:  Jakob Schnedl; Herbert Auer; Marcellus Fischer; Herbert Tomaso; Tom Pustelnik; Gerhard Mooseder
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

Review 3.  [Cutaneous leishmaniasis].

Authors:  C D Enk; K Gardlo; M Hochberg; A Ingber; T Ruzicka
Journal:  Hautarzt       Date:  2003-04-18       Impact factor: 0.751

4.  Active suppression induced by cutaneous exposure to bacterial superantigen is prevented by interleukin-12 treatment in vivo.

Authors:  J Saloga; A H Enk; D Becker; I Bellinghausen; S Kühn; J Knop
Journal:  Immunology       Date:  1998-04       Impact factor: 7.397

5.  Double blind, randomized controlled trial, to evaluate the effectiveness of a controlled nitric oxide releasing patch versus meglumine antimoniate in the treatment of cutaneous leishmaniasis [NCT00317629].

Authors:  Sandra Y Silva; Ligia C Rueda; Marcos López; Iván D Vélez; Christian F Rueda-Clausen; Daniel J Smith; Gerardo Muñoz; Hernando Mosquera; Federico A Silva; Adriana Buitrago; Holger Díaz; Patricio López-Jaramillo
Journal:  Trials       Date:  2006-05-15       Impact factor: 2.279

6.  Molecular epidemiology of imported cases of leishmaniasis in Australia from 2008 to 2014.

Authors:  Tamalee Roberts; Joel Barratt; Indy Sandaradura; Rogan Lee; John Harkness; Deborah Marriott; John Ellis; Damien Stark
Journal:  PLoS One       Date:  2015-03-03       Impact factor: 3.240

7.  Species-directed therapy for leishmaniasis in returning travellers: a comprehensive guide.

Authors:  Caspar J Hodiamont; Piet A Kager; Aldert Bart; Henry J C de Vries; Pieter P A M van Thiel; Tjalling Leenstra; Peter J de Vries; Michèle van Vugt; Martin P Grobusch; Tom van Gool
Journal:  PLoS Negl Trop Dis       Date:  2014-05-01

8.  Interventions for American cutaneous and mucocutaneous leishmaniasis.

Authors:  Mariona Pinart; José-Ramón Rueda; Gustavo As Romero; Carlos Eduardo Pinzón-Flórez; Karime Osorio-Arango; Ana Nilce Silveira Maia-Elkhoury; Ludovic Reveiz; Vanessa M Elias; John A Tweed
Journal:  Cochrane Database Syst Rev       Date:  2020-08-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.